Plenary I: Evolution of Headache Medicine
Friday, November 17, 2023 |
8:30 AM - 10:20 AM |
Arizona Ballroom Salon A-G |
Details
Speaker
Todd Schwedt
Mayo Clinic
Pathophysiology – What Does it Mean for your Patients?
8:30 AM - 8:55 AM
Peter Goadsby
Professor Emeritus
UCLA
Development of CGRP Targeted Therapy
8:55 AM - 9:20 AMPresentation Description
The presentation will cover the biological, experimental medicine and translation neuroscience thinking and progress behind the evolution of CGRP directed therapies.
Deborah Friedman
Yellow Rose Headache and Neuro-Ophthalmology
Are “Traditional” Prescription Headache Medications Still Relevant?
9:20 AM - 9:45 AMPresentation Description
With the advent of oral and parenteral CGRP antagonists, are the older "traditional" preventive and acute medications still valuable? This presentation will explore clinical trial data, including comparative data, situations in which older medications may be beneficial or harmful, and financial considerations as we to navigate our expanding migraine treatment landscape.
Andrew Charles
UCLA
The Future of Headache Therapeutics
9:45 AM - 10:05 AMPresentation Description
This presentation will describe new therapeutic targets for headache disorders that are being developed based upon new understanding of fundamental mechanisms of headache. Therapeutic targets to be discussed include the hypothalamus, upper cervical nerves, adenosine receptors, amylin, pituitary adenylate cyclase activating peptide (PACAP), and glutamate and its receptors.
Moderator
Shivang Joshi
Community Neuroscience Services
Elizabeth Loder
Department of Neurology, Brigham and Women's Hospital, Boston, MA
![loading](/Content/Images/loader-large.gif)